Theriva Biologics, Inc. · AMEX:TOVX
Theriva Biologics, Inc. shareholders
As of Jun 30, 2026, 24 institutions reported holding Theriva Biologics, Inc., 4.3% of its shares. Largest: Vanguard, Jane Street and Geode Capital. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Theriva Biologics, Inc. | Change | Filed |
|---|---|---|---|---|
| Vanguard | 728K | 1.6% | +294K | Aug 13, 2026 |
| Jane Street | 332K | 0.72% | +155K | Aug 14, 2026 |
| Geode Capital | 294K | 0.64% | −156K | Aug 12, 2026 |
| Ikarian Capital, LLC | 112K | 0.24% | no change | Aug 14, 2026 |
| Virtu Financial LLC | 87,138 | 0.19% | −166K | Aug 13, 2026 |
| Northern Trust | 82,700 | 0.18% | new | Aug 13, 2026 |
| Renaissance Technologies | 63,710 | 0.14% | new | Aug 13, 2026 |
| UBS | 61,053 | 0.13% | −165K | Aug 13, 2026 |
| XTX Topco Ltd | 53,868 | 0.12% | −40,752 | Aug 14, 2026 |
| Ground Swell Capital, LLC | 35,292 | 0.08% | new | Aug 5, 2026 |